Provided by Tiger Fintech (Singapore) Pte. Ltd.

Redhill Biopharma

2.00
+0.02001.01%
Post-market: 2.000.00000.00%18:07 EDT
Volume:8.06K
Turnover:16.06K
Market Cap:3.50M
PE:-0.30
High:2.03
Open:1.99
Low:1.94
Close:1.98
Loading ...
Mar 11, 2019

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Mar 04, 2019

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Feb 26, 2019

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Feb 21, 2019

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Feb 20, 2019

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Feb 19, 2019

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Jan 17, 2019

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Dec 11, 2018

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Dec 10, 2018

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Dec 06, 2018

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Dec 04, 2018

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Dec 03, 2018

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Nov 29, 2018

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Nov 14, 2018

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Nov 13, 2018

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Nov 06, 2018

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Oct 29, 2018

Report of foreign issuer

Oct 25, 2018

Report of foreign issuer

Oct 24, 2018

Report of foreign issuer

Oct 22, 2018

Report of foreign issuer